AFC-HD AMS Life Science Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended November 2018; Provides Consolidated Earnings Guidance for the Six Months Ending February 2019 and Year Ending August 2019
January 09, 2019 at 01:10 am
Share
AFC-HD AMS Life Science Co., Ltd. reported consolidated earnings results for the first quarter ended November 2018. For the quarter, the company reported net sales of JPY 4,261 million against JPY 3,844 million a year ago. Operating profit was JPY 330 million against JPY 269 million a year ago. Profit attributable to owners of parent was JPY 227 million against JPY 177 million a year ago. Basic earnings per share was JPY 16.15 against JPY 14.66 a year ago.
For the year ending August 2019, on consolidated basis, the company expects net sales of JPY 16,000 million, operating profit of JPY 1,050 million, profit attributable to owners of parent of JPY 770 million and basic earnings per share of JPY 54.75.
For the six months ending February 2019, on consolidated basis, the company expects net sales of JPY 7,950 million, operating profit of JPY 500 million, profit attributable to owners of parent of JPY 400 million and basic earnings per share of JPY 28.44.
AFC-HD AMS Life Science Co Ltd is a Japan-based company mainly engaged in the development of the healthcare business and the pharmaceutical business. The Company is engaged in the research and development, product design, manufacture and sale of health foods and cosmetics, manufacture and sale of Chinese medicine medicines, general medicines, generic medicines, healthcare products, the sale of natural foods, as well as planning of health information programs. The Company operates in two business segments. The Healthcare segment is engaged in the manufacture and sale of health foods and cosmetics, as well as the provision of original equipment manufacturers (OEM). The Pharmaceutical segment is engaged in the manufacture and sale of ethical drugs and over-the-counter drugs, as well as the sale of generic drugs. The Company is also engaged in the management of restaurants through subsidiary.
AFC-HD AMS Life Science Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended November 2018; Provides Consolidated Earnings Guidance for the Six Months Ending February 2019 and Year Ending August 2019
AFC-HD AMS LIFE SCIENCE CO., LTD. 
